BL Pharmtech비엘팜텍
065170 · KOSDAQ · ₩065170 · 비엘팜텍
₩1,791▲ ₩24 (1.36%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 37.1% | 56.7% | 67.2% | 55.3% | 21.9% | 25.0% |
| Operating margin | −95.0% | −43.4% | −36.5% | −27.7% | −3.4% | −4.1% |
| Net margin | −517.9% | −257.9% | −64.8% | −0.6% | −17.3% | −23.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −52.5% | −26.1% | −64.1% | −69.6% | −4.6% | — |
| Operating income growth | −4.0% | +12.2% | +52.7% | −144.7% | +19.1% | — |
| Net income growth | +4.6% | −194.0% | −3,733.7% | +98.9% | +31.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −197.3% | −104.4% | −20.5% | −0.5% | −30.1% | −34.6% |
| Return on assets | −96.8% | −61.4% | −14.1% | 0.2% | −11.7% | −15.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 104.5% | 129.5% | 50.2% | 40.9% | 152.4% | 99.0% |
| Net debt to equity | −32.5% | −33.8% | 5.4% | −21.6% | 89.5% | 29.9% |
| Current ratio | 94.9% | 95.4% | 104.7% | 212.4% | 66.6% | 114.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: BL Pharmtech / 비엘팜텍 / 065170 / KRX:065170
Source: KRX statistical information